The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Conformal Coating of Stem Cell-Derived Islets for β Cell Replacement in Type 1 Diabetes
Abstract
The scarcity of donors and need for immunosuppression limit pancreatic islet transplantation to a few patients with labile type 1 diabetes. Transplantation of encapsulated stem cell-derived islets (SC islets) might extend the applicability of islet transplantation to a larger cohort of patients. Transplantation of conformal-coated islets into a confined well-vascularized site allows long-term diabetes reversal in fully MHC-mismatched diabetic mice without immunosuppression. Here, we demonstrated that human SC islets reaggregated from cryopreserved cells display glucose-stimulated insulin secretion in vitro. Importantly, we showed that conformally coated SC islets displayed comparable in vitro function with unencapsulated SC islets, with conformal coating permitting physiological insulin secretion. Transplantation of SC islets into the gonadal fat pad of diabetic NOD-scid mice revealed that both unencapsulated and conformal-coated SC islets could reverse diabetes and maintain human-level euglycemia for more than 80 days. Overall, these results provide support for further evaluation of safety and efficacy of conformal-coated SC islets in larger species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This target cell mass is currently beyond reach of existing planar or suspension platforms.”
From Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors (2025) · cites this paper as [33]
In the citing paper
“Stock et al. observed extensive cell loss up to 8 days post reaggregation, resulting in a total yield of ~21%33.”
From Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors (2025) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Generation of Functional Human Pancreatic β Cells In Vitro
Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., Peterson, Q. P., Greiner, D., & Melton, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.040 · Cited by 2,025 · cited 11×
“After thawing, S6 d1 cells were reaggregated into SC islets by suspension culture (ABLE Biott, distributed by Reprocell, Betsville, MD) at 60 rpm, 37 C, 5% CO2, and 95% humidity in MCDB medium supplemented with 2% BSA and 13 GlutaMAX (Semma Therapeutics) (Pagliuca et al., 2014).”
BackgroundMethodResultInfluentialSelf-citationKroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1393 · Cited by 1,843 · cited 2×
“In contrast to previous stem cell-derived insulin-secreting cell products requiring further differentiation in vivo after transplantation (Kroon et al., 2008), these SC islets are terminally differentiated at the time of transplantation and have shown efficacy in diabetes reversal in vivo in rodent models (Pagliuca et…”
BackgroundResultVegas, A. J., Veiseh, O., Gürtler, M., Millman, J. R., Pagliuca, F. W., Bader, A. R., Doloff, J. C., Li, J., Chen, M., Olejnik, K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4030 · Cited by 710 · cited 5×
“, 2014) and observed by other groups (Vegas et al., 2016).”
BackgroundInfluentialSelf-citationScharp, D. W., & Marchetti, P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.018 · Cited by 314
Redondo, M. J., Steck, A. K., & Pugliese, A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12597 · Cited by 216
Qayyum, A. S., Jain, E., Kolar, G., Kim, Y., Sell, S. A., & Zustiak, S. P. (2017) · Biofabrication · doi:10.1088/1758-5090/aa703c · Cited by 89
Microencapsulation in Clinical Islet Xenotransplantation
Shimoda, M., & Matsumoto, S. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6364-5_25 · Cited by 18 · cited 1×
“, 2018) and grant long-term insulin independence in the clinical setting (Calafiore and Basta, 2014; Shimoda and Matsumoto, 2017; Vaithilingam et al., 2017).”
Background
Research works printed but not linked: 46
- Abdul-Ghani, 2010, The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes, Diabetes Metab. Res. Rev., 26, 280, 10.1002/dmrr.1084 · DOI · Paper page
- Allen, 1966, The thermal reversibility of the Michael reaction: V. The effect of the structure of certain thiol adducts on cleavage, Can. J. Chem., 44, 2315, 10.1139/v66-347 · doi:10.1139/v66-347
- Barkai, 2016, Survival of encapsulated islets: more than a membrane story, World J. Transplant., 6, 69, 10.5500/wjt.v6.i1.69 · DOI
- Berman, 2016, Bioengineering the endocrine pancreas: intraomental islet transplantation within a biologic resorbable scaffold, Diabetes, 65, 1350, 10.2337/db15-1525 · DOI
- Berney, 2010, Donor pancreata: evolving approaches to organ allocation for whole pancreas versus islet transplantation, Transplantation, 90, 238, 10.1097/TP.0b013e3181e25a40 · DOI
- Brubaker, 2015, Crystalline oligo(ethylene sulfide) domains define highly stable supramolecular block copolymer assemblies, ACS Nano, 9, 6872, 10.1021/acsnano.5b02937 · DOI
- Buchwald, 2018, Glucose-stimulated insulin release: parallel perifusion studies of free and hydrogel encapsulated human pancreatic islets, Biotechnol. Bioeng., 115, 232, 10.1002/bit.26442 · DOI
- Calafiore, 2014, Clinical application of microencapsulated islets: actual prospectives on progress and challenges, Adv. Drug Deliv. Rev., 67-68, 84, 10.1016/j.addr.2013.09.020 · DOI
- Chen, 2015, Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression, Am. J. Transplant., 15, 618, 10.1111/ajt.13049 · DOI
- D'Amour, 2006, Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells, Nat. Biotechnol., 24, 1392, 10.1038/nbt1259 · DOI · Paper page
- Dean, 2017, Pancreas transplantation, BMJ, 357, j1321, 10.1136/bmj.j1321 · DOI
- Dionne, 1993, Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans, Diabetes, 42, 12, 10.2337/diab.42.1.12 · DOI · Paper page
- Duvillie, 2013, Vascularization of the pancreas: an evolving role from embryogenesis to adulthood, Diabetes, 62, 4004, 10.2337/db13-1421 · DOI
- Garcia, 2014, PEG-maleimide hydrogels for protein and cell delivery in regenerative medicine, Ann. Biomed. Eng., 42, 312, 10.1007/s10439-013-0870-y · DOI
- Hering, 2016, Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia, Diabetes Care, 39, 1230, 10.2337/dc15-1988 · DOI · Paper page
- Kharkar, 2016, Thiol-ene click hydrogels for therapeutic delivery, ACS Biomater. Sci. Eng., 2, 165, 10.1021/acsbiomaterials.5b00420 · DOI · Paper page
- Korsgren, 2017, Islet encapsulation: physiological possibilities and limitations, Diabetes, 66, 1748, 10.2337/db17-0065 · DOI
- Krishnan, 2017, Immunological challenges facing translation of alginate encapsulated porcine islet xenotransplantation to human clinical trials, Methods Mol. Biol., 1479, 305, 10.1007/978-1-4939-6364-5_24 · DOI
- Lee, 2012, Alginate: properties and biomedical applications, Prog. Polym. Sci., 37, 106, 10.1016/j.progpolymsci.2011.06.003 · DOI · Paper page
- Manzoli, 2018, Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol, Am. J. Transplant., 18, 590, 10.1111/ajt.14547 · DOI
- Markmann, 2016, Executive summary of IPITA-TTS opinion leaders report on the future of beta-cell replacement, Transplantation, 100, 10.1097/TP.0000000000001054 · DOI
- Merani, 2008, Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice, Endocrinology, 149, 4322, 10.1210/en.2008-0501 · DOI
- Millman, 2017, Autologous pluripotent stem cell-derived beta-like cells for diabetes cellular therapy, Diabetes, 66, 1111, 10.2337/db16-1406 · DOI
- Millman, 2016, Generation of stem cell-derived beta-cells from patients with type 1 diabetes, Nat. Commun., 7, 11463, 10.1038/ncomms11463 · DOI · Paper page
- Muthyala, 2017, The effect of hypoxia on free and encapsulated adult porcine islets-an in vitro study, Xenotransplantation, 24, 10.1111/xen.12275 · DOI
- Nishimura, 2017, Effects of encapsulated porcine islets on glucose and C-peptide concentrations in diabetic nude mice 6 months after intraperitoneal transplantation, Xenotransplantation, 24, 10.1111/xen.12313 · DOI
- Nunamaker, 2007, In vivo stability and biocompatibility of implanted calcium alginate disks, J. Biomed. Mater. Res. A, 83, 1128, 10.1002/jbm.a.31275 · DOI
- O'Shea, 1984, Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane, Biochim. Biophys. Acta, 804, 133, 10.1016/0167-4889(84)90107-1 · DOI · Paper page
- Orive, 2018, Engineering a clinically translatable bioartificial pancreas to treat type I diabetes, Trends Biotechnol., 36, 445, 10.1016/j.tibtech.2018.01.007 · DOI
- Papas, 2016, Effect of oxygen supply on the size of implantable islet-containing encapsulation devices, Panminerva Med., 58, 72
- Papas, 2015, Islet oxygen consumption rate (OCR) dose predicts insulin independence in clinical islet autotransplantation, PLoS One, 10, e0134428, 10.1371/journal.pone.0134428 · DOI
- Rodriguez-Diaz, 2018, Paracrine interactions within the pancreatic islet determine the glycemic set point, Cell Metab., 27, 549, 10.1016/j.cmet.2018.01.015 · DOI · Paper page
- Safley, 2018, Microencapsulated adult porcine islets transplanted intraperitoneally in streptozotocin-diabetic non-human primates, Xenotransplantation, 25, e12450, 10.1111/xen.12450 · DOI
- Salama, 2017, Porcine islet xenografts: a clinical source of ss-cell grafts, Curr. Diab. Rep., 17, 14, 10.1007/s11892-017-0846-7 · DOI
- Schneider, 2005, Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent diabetic mice, Diabetes, 54, 687, 10.2337/diabetes.54.3.687 · DOI
- Schuetz, 2016, Islet cell transplant: update on current clinical trials, Curr. Transplant. Rep., 3, 254, 10.1007/s40472-016-0103-z · DOI
- Shapiro, 2017, Clinical pancreatic islet transplantation, Nat. Rev. Endocrinol., 13, 268, 10.1038/nrendo.2016.178 · DOI · Paper page
- Skyler, 2018, Hope vs hype: where are we in type 1 diabetes?, Diabetologia, 61, 509, 10.1007/s00125-017-4530-x · DOI · Paper page
- Smith, 2017, Acute ischemia induced by high-density culture increases cytokine expression and diminishes the function and viability of highly purified human islets of langerhans, Transplantation, 101, 2705, 10.1097/TP.0000000000001714 · DOI
- Stegall, 1996, Evidence of recurrent autoimmunity in human allogeneic islet transplantation, Transplantation, 61, 1272, 10.1097/00007890-199604270-00027 · DOI
- Tomei, 2014, Device design and materials optimization of conformal coating for islets of Langerhans, Proc. Natl. Acad. Sci. U S A, 111, 10514, 10.1073/pnas.1402216111 · DOI · Paper page
- Tomei, 2015, Development of an encapsulated stem cell-based therapy for diabetes, Expert Opin. Biol. Ther., 15, 1321, 10.1517/14712598.2015.1055242 · DOI
- Vaithilingam, 2017, Encapsulated islet transplantation: where do we stand? The review of diabetic studies, Rev. Diabet. Stud., 14, 51, 10.1900/RDS.2017.14.51 · DOI
- Veres, 2019, Charting cellular identity during human in vitro beta-cell differentiation, Nature, 569, 368, 10.1038/s41586-019-1168-5 · DOI · Paper page
- Verheyen, 2019, Characterization of polyethylene glycol–reinforced alginate microcapsules for mechanically stable cell immunoisolation, Macromol. Mater. Eng., 304, 10.1002/mame.201800679 · DOI
- Villa, 2017, Effects of composition of alginate-polyethylene glycol microcapsules and transplant site on encapsulated islet graft outcomes in mice, Transplantation, 101, 1025, 10.1097/TP.0000000000001454 · DOI
Cited by
Lu, P., Ruan, D., Huang, M., Tian, M., Zhu, K., Gan, Z., & Xiao, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01852-x · Cited by 667
Engineering islets from stem cells for advanced therapies of diabetes
Siehler, J., Blöchinger, A. K., Meier, M., & Lickert, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00262-w · Cited by 125
Grattoni, A., Korbutt, G., Tomei, A. A., García, A. J., Pepper, A. R., Stabler, C., Brehm, M., Papas, K., Citro, A., Shirwan, H., et al. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01029-0 · Cited by 92
Self-citationDifferential Function and Maturation of Human Stem Cell-Derived Islets After Transplantation
Maxwell, K. G., Kim, M. H., Gale, S. E., & Millman, J. R. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szab013 · Cited by 54
Samojlik, M. M., & Stabler, C. L. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.039 · Cited by 38
Metadata
- Authors
- Stock, A. A., Manzoli, V., De Toni, T., Abreu, M. M., Poh, Y.-C., Ye, L., Roose, A., Pagliuca, F. W., Thanos, C., Ricordi, C., & Tomei, A. A.
- Venue
- Stem Cell Reports
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 14
- Issue
- 1
- Pages
- 91-104
- ISSN
- 2213-6711
- Cited by
- 96
- References
- 8
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Semma Therapeutics
- Diabetes Research Institute Foundation
- National Institutes of Health (DK109929)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.